Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

GLYBURIDE Drug Profile

« Back to Dashboard

Which patents cover Glyburide, and when can generic versions of Glyburide launch?

Glyburide is a drug marketed by Aurobindo Pharma, Heritage Pharms Inc, Actavis Elizabeth, Zydus Pharms Usa Inc, Corepharma, Impax Labs Inc, Pharmadax Inc, Teva, Sanofi Aventis Us, Sandoz, Hikma, Dava Pharms Inc, and Mylan. and is included in twenty-one NDAs.

The generic ingredient in GLYBURIDE is glyburide; metformin hydrochloride. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the glyburide; metformin hydrochloride profile page.

Summary for Tradename: GLYBURIDE

Suppliers / Packagers: see list36
Bulk Api Vendors: see list84
Clinical Trials: see list20
Patent Applications: see list6,266
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GLYBURIDE at DailyMed

Pharmacology for Tradename: GLYBURIDE

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TABLET;ORAL074792-001Jun 26, 1998ABRXNoNo► Subscribe► Subscribe
TABLET;ORAL074686-003Apr 20, 1999ABRXNoNo► Subscribe► Subscribe
Actavis Elizabeth
glyburide; metformin hydrochloride
TABLET;ORAL076716-003Jun 28, 2005ABRXNoNo► Subscribe► Subscribe
Zydus Pharms Usa Inc
glyburide; metformin hydrochloride
TABLET;ORAL206748-002Feb 29, 2016ABRXNoNo► Subscribe► Subscribe
Heritage Pharms Inc
glyburide; metformin hydrochloride
TABLET;ORAL079009-002Jun 3, 2009ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus